E137: Obexelimab in IgG4-RD (INDIGO)

The Evidence Based Rheumatology Podcast by Michael Putman

Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less efficacious maybe less toxic" pathway. I could see folks being excited for this, especially in a disease where non...View more